A joint study between Yale University, King’s College Hospital in London and Doctors Without Borders found a single shot could be made for just 89 cents.
anybody who believes pharma costs are justified by materials is… well, let’s just call them uninformed. It’s not justified by R&D costs or production issues. It’s justified by the stock market, by the CEO having a race with other pharma CEOs for the biggest bonus, and by no other thing.
I work in med device, close to pharma, but a bit different. There is a lot of overhead. Beyond all the validations required for startup of each line, there is quite a lot of Sustaining work.
I’m not trying to defend this price, or the gouging that pharma does regularly. But I don’t think the $5 price includes all the overhead of the QMS.
Well if the materials to make a pizza was 5 dollars and it was being sold at 1,000 dollars, saying “oh thats just necessary overhead” would lead me to wonder why the hell that level of inefficiency was tolerated.
Because each new type of pizza is made of brand-new ingredients, not just standard wheat flour, tomatoes, cheese, spices, etc. And they’re baked anew and taste-tested to make sure they’re not disgusting, or worse, have toxic effects.
Normally you can think of these prices as the reward to taking a risk. The chance of developing a drug and bringing it to market is usually small, and the reward should accordingly be high. However, in the particular case of Ozempic, the company attempted to develop a diabetes drug, and accidentally found that the drug works against obesity. That means that the reward in this case outweighs the risk by an obscene amount.
obviously
anybody who believes pharma costs are justified by materials is… well, let’s just call them uninformed. It’s not justified by R&D costs or production issues. It’s justified by the stock market, by the CEO having a race with other pharma CEOs for the biggest bonus, and by no other thing.
I work in med device, close to pharma, but a bit different. There is a lot of overhead. Beyond all the validations required for startup of each line, there is quite a lot of Sustaining work.
I’m not trying to defend this price, or the gouging that pharma does regularly. But I don’t think the $5 price includes all the overhead of the QMS.
It’s like taking the price of the ingredients for a pizza and saying it’s what it should cost.
Well if the materials to make a pizza was 5 dollars and it was being sold at 1,000 dollars, saying “oh thats just necessary overhead” would lead me to wonder why the hell that level of inefficiency was tolerated.
Because each new type of pizza is made of brand-new ingredients, not just standard wheat flour, tomatoes, cheese, spices, etc. And they’re baked anew and taste-tested to make sure they’re not disgusting, or worse, have toxic effects.
Patents, e.g. legal monopolies.
Maybe fines and penalties for undercutting someone who holds a patent should be scrapped for nonprofit manufacturers of generics.
Maybe profit should come second to the betterment of humanity.
I’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap.
The problem still stands, though, and the solution is capping executive pay in public companies.
It’s justified by asking “how much money can we suck out of the people it helps?”
Normally you can think of these prices as the reward to taking a risk. The chance of developing a drug and bringing it to market is usually small, and the reward should accordingly be high. However, in the particular case of Ozempic, the company attempted to develop a diabetes drug, and accidentally found that the drug works against obesity. That means that the reward in this case outweighs the risk by an obscene amount.